• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食与非酒精性脂肪性肝病:地中海饮食方式。

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way.

机构信息

Department of Health Sciences, University "Magna Graecia", Viale Europa-Germaneto, 88110 Catanzaro, Italy.

Greenwood Genetic Center, 113 Gregor Mendel Circle, Greenwood, SC 29646, USA.

出版信息

Int J Environ Res Public Health. 2019 Aug 21;16(17):3011. doi: 10.3390/ijerph16173011.

DOI:10.3390/ijerph16173011
PMID:31438482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6747511/
Abstract

Lifestyle interventions remain the first-line treatment for non-alcoholic fatty liver disease (NAFLD), even if the optimal alimentary regimen is still controversial. The interest in antioxidants has increased over time, and literature reports an inverse association between nutrients rich in antioxidants and the risk of mortality due to non-communicable diseases, including NAFLD. Mediterranean diet (MD) is a model characterized by main consumption of plant-based foods and fish and reduced consumption of meat and dairy products. MD represents the gold standard in preventive medicine, probably due to the harmonic combination of many foods with antioxidant and anti-inflammatory properties. This regimen contributes substantially to the reduction of the onset of many chronic diseases as cardiovascular diseases, hypertension, type 2 diabetes mellitus, obesity, cancer, and NAFLD. The present review aims to clarify the intake of antioxidants typical of the MD and evaluate their effect on NAFLD.

摘要

生活方式干预仍然是非酒精性脂肪性肝病 (NAFLD) 的一线治疗方法,即使最佳饮食方案仍存在争议。抗氧化剂的研究兴趣日益增加,文献报道富含抗氧化剂的营养素与非传染性疾病(包括 NAFLD)导致的死亡率呈负相关。地中海饮食 (MD) 是一种以植物性食物和鱼类为主,减少肉类和奶制品摄入的模式。MD 是预防医学的金标准,可能是由于许多具有抗氧化和抗炎特性的食物的和谐组合。这种饮食方案在减少许多慢性疾病的发生方面发挥了重要作用,如心血管疾病、高血压、2 型糖尿病、肥胖症、癌症和 NAFLD。本综述旨在阐明 MD 中典型的抗氧化剂的摄入量,并评估其对 NAFLD 的影响。

相似文献

1
Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way.饮食与非酒精性脂肪性肝病:地中海饮食方式。
Int J Environ Res Public Health. 2019 Aug 21;16(17):3011. doi: 10.3390/ijerph16173011.
2
Olive oil antioxidants and non-alcoholic fatty liver disease.橄榄油抗氧化剂与非酒精性脂肪性肝病。
Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):739-749. doi: 10.1080/17474124.2019.1634544. Epub 2019 Jun 25.
3
Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.非酒精性脂肪性肝病的饮食疗法:地中海饮食
World J Gastroenterol. 2014 Dec 7;20(45):16831-40. doi: 10.3748/wjg.v20.i45.16831.
4
The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms.地中海饮食模式作为非酒精性脂肪肝的首选饮食:证据和可能的机制。
Liver Int. 2017 Jul;37(7):936-949. doi: 10.1111/liv.13435. Epub 2017 Jun 1.
5
Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study.地中海饮食和抗氧化配方对非酒精性脂肪肝的影响:一项随机研究。
Nutrients. 2017 Aug 12;9(8):870. doi: 10.3390/nu9080870.
6
Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review.非酒精性脂肪性肝病与地中海生活方式的关联:系统评价。
Nutrients. 2021 Dec 23;14(1):49. doi: 10.3390/nu14010049.
7
Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.基于地中海生活方式的干预对非酒精性脂肪性肝病患者临床特征的改善:一项随机对照临床试验。
Br J Nutr. 2018 Jul;120(2):164-175. doi: 10.1017/S000711451800137X.
8
Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.坚持地中海饮食与非酒精性脂肪性肝病:对胰岛素抵抗的影响。
Am J Gastroenterol. 2017 Dec;112(12):1832-1839. doi: 10.1038/ajg.2017.371. Epub 2017 Oct 24.
9
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: results from a case-control study.地中海饮食与非酒精性脂肪性肝病的预防:一项病例对照研究的结果。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7391-7398. doi: 10.26355/eurrev_202007_21907.
10
Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review.膳食模式、食物和营养素改善非酒精性脂肪性肝病:范围综述。
Nutrients. 2023 Sep 14;15(18):3987. doi: 10.3390/nu15183987.

引用本文的文献

1
Integrating liver and heart health: Cardiovascular risk reduction in patients with metabolic-associated steatotic liver disease.整合肝脏与心脏健康:降低代谢相关脂肪性肝病患者的心血管风险
World J Cardiol. 2025 Jul 26;17(7):107751. doi: 10.4330/wjc.v17.i7.107751.
2
Adherence to the Mediterranean diet to prevent or delay hepatic steatosis: a longitudinal analysis within the PREDIMED study.坚持地中海饮食以预防或延缓肝脂肪变性:PREDIMED研究中的纵向分析。
Front Nutr. 2025 May 21;12:1518082. doi: 10.3389/fnut.2025.1518082. eCollection 2025.
3
Frequency of insulin resistance among non-diabetic patients with non-alcoholic fatty liver disease using HOMA-IR: an experience of a tertiary care hospital in Karachi, Pakistan.使用稳态模型评估胰岛素抵抗指数(HOMA-IR)评估非酒精性脂肪性肝病非糖尿病患者的胰岛素抵抗频率:巴基斯坦卡拉奇一家三级医院的经验
BMC Gastroenterol. 2025 Apr 15;25(1):259. doi: 10.1186/s12876-025-03790-6.
4
Association between composite dietary antioxidant index and rheumatoid arthritis: results from NHANES 2003-2018.复合膳食抗氧化指数与类风湿性关节炎之间的关联:2003 - 2018年美国国家健康与营养检查调查结果
Int J Med Sci. 2025 Feb 18;22(5):1184-1193. doi: 10.7150/ijms.107332. eCollection 2025.
5
The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment.风险三联征:连接代谢相关脂肪性肝病、心血管疾病和2型糖尿病;从病理生理学到治疗
J Clin Med. 2025 Jan 10;14(2):428. doi: 10.3390/jcm14020428.
6
Associations between intake of different types of vegetables and metabolic dysfunction-associated fatty liver disease: a population-based study.不同类型蔬菜摄入量与代谢功能障碍相关脂肪性肝病之间的关联:一项基于人群的研究。
BMC Public Health. 2025 Jan 24;25(1):315. doi: 10.1186/s12889-025-21331-4.
7
Association between neutrophil-albumin ratio and ultrasound-defined metabolic dysfunction-associated fatty liver disease in U.S. adults: evidence from NHANES 2017-2018.美国成年人中性粒细胞与白蛋白比值和超声定义的代谢功能障碍相关脂肪性肝病之间的关联:来自2017 - 2018年美国国家健康与营养检查调查(NHANES)的证据
BMC Gastroenterol. 2025 Jan 17;25(1):20. doi: 10.1186/s12876-025-03612-9.
8
The effect of ertugliflozin in patients with nonalcoholic fatty liver disease associated with type 2 diabetes mellitus: A randomized controlled trial.在伴有 2 型糖尿病的非酒精性脂肪性肝病患者中,厄格列净的疗效:一项随机对照试验。
Medicine (Baltimore). 2024 Nov 8;103(45):e40356. doi: 10.1097/MD.0000000000040356.
9
Green Tea Polyphenol (-)-Epicatechin Pretreatment Mitigates Hepatic Steatosis in an In Vitro MASLD Model.绿茶多酚(-)-表儿茶素预处理可减轻体外MAFLD模型中的肝脂肪变性。
Curr Issues Mol Biol. 2024 Aug 16;46(8):8981-8994. doi: 10.3390/cimb46080531.
10
Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease.机器学习发现锰是一种与降低脂肪性肝病风险相关的关键营养素。
Liver Int. 2024 Oct;44(10):2807-2821. doi: 10.1111/liv.16055. Epub 2024 Jul 31.

本文引用的文献

1
Pathogenesis of NASH: The Impact of Multiple Pathways.非酒精性脂肪性肝炎的发病机制:多种途径的影响
Curr Hepatol Rep. 2018 Dec;17(4):350-360. doi: 10.1007/s11901-018-0425-7. Epub 2018 Oct 31.
2
Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.减肥干预措施与非酒精性脂肪性肝病生物标志物变化的关联:一项系统评价和荟萃分析。
JAMA Intern Med. 2019 Sep 1;179(9):1262-1271. doi: 10.1001/jamainternmed.2019.2248.
3
Benefits of the Mediterranean diet: Epidemiological and molecular aspects.地中海饮食的益处:流行病学和分子角度。
Mol Aspects Med. 2019 Jun;67:1-55. doi: 10.1016/j.mam.2019.06.001. Epub 2019 Jul 4.
4
Olive oil antioxidants and non-alcoholic fatty liver disease.橄榄油抗氧化剂与非酒精性脂肪性肝病。
Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):739-749. doi: 10.1080/17474124.2019.1634544. Epub 2019 Jun 25.
5
Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.益生菌和合生菌治疗非酒精性脂肪性肝病的疗效:Meta 分析。
Dig Dis Sci. 2019 Dec;64(12):3402-3412. doi: 10.1007/s10620-019-05699-z. Epub 2019 Jun 15.
6
A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH).非酒精性脂肪性肝炎(NASH)的流行病学和疾病负担的结构化文献综述。
Adv Ther. 2019 Jul;36(7):1574-1594. doi: 10.1007/s12325-019-00960-3. Epub 2019 May 7.
7
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学、风险评估及诊断挑战
Medicines (Basel). 2019 Mar 18;6(1):41. doi: 10.3390/medicines6010041.
8
The Mediterranean Diet: From an Environment-Driven Food Culture to an Emerging Medical Prescription.地中海饮食:从环境驱动的食物文化到新兴的医疗处方。
Int J Environ Res Public Health. 2019 Mar 15;16(6):942. doi: 10.3390/ijerph16060942.
9
Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.肠-肝轴、肠道微生物群及其在肝脏疾病治疗中的调控:文献综述。
Int J Mol Sci. 2019 Jan 17;20(2):395. doi: 10.3390/ijms20020395.
10
Non-alcoholic fatty liver disease - A global public health perspective.非酒精性脂肪性肝病——全球公共卫生视角。
J Hepatol. 2019 Mar;70(3):531-544. doi: 10.1016/j.jhep.2018.10.033. Epub 2018 Nov 9.